[
  {
    "ts": null,
    "headline": "Cheapest S&P 500 Stocks Ranked: 30 Best Value Buys",
    "summary": "Discover 30 top large-cap stocks offering strong value and quality.",
    "url": "https://finnhub.io/api/news?id=128fd721f9f6e5596b2df433e7890d99c8fbaabc25a5e6304c77ff2d7740de20",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759141719,
      "headline": "Cheapest S&P 500 Stocks Ranked: 30 Best Value Buys",
      "id": 136915123,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189068007/image_2189068007.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Discover 30 top large-cap stocks offering strong value and quality.",
      "url": "https://finnhub.io/api/news?id=128fd721f9f6e5596b2df433e7890d99c8fbaabc25a5e6304c77ff2d7740de20"
    }
  },
  {
    "ts": null,
    "headline": "Amgen to invest $650m in US manufacturing network expansion",
    "summary": "The investment aims to scale up the production of drugs at the company’s Juncos’ biologics production facility.",
    "url": "https://finnhub.io/api/news?id=451e187e0e6a5132d1dcac2910364c3b58886660370486fc2a7451791c6f6c9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759134575,
      "headline": "Amgen to invest $650m in US manufacturing network expansion",
      "id": 136913716,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The investment aims to scale up the production of drugs at the company’s Juncos’ biologics production facility.",
      "url": "https://finnhub.io/api/news?id=451e187e0e6a5132d1dcac2910364c3b58886660370486fc2a7451791c6f6c9e"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency",
    "summary": "​Amgen Inc. (NASDAQ:AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Amgen Inc.’s (NASDAQ:AMGN) and AstraZeneca’s Tezspire received a positive recommendation from the European Medicines Agency Committee for Medicinal Products for Human Use. ​The approval is for treating adults with chronic rhinosinusitis with nasal polyps in […]",
    "url": "https://finnhub.io/api/news?id=7c2b79a36a512c5d95e15a72f12599d93909b9b83667023e190abc95c068bf76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759124380,
      "headline": "Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency",
      "id": 136913717,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "​Amgen Inc. (NASDAQ:AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Amgen Inc.’s (NASDAQ:AMGN) and AstraZeneca’s Tezspire received a positive recommendation from the European Medicines Agency Committee for Medicinal Products for Human Use. ​The approval is for treating adults with chronic rhinosinusitis with nasal polyps in […]",
      "url": "https://finnhub.io/api/news?id=7c2b79a36a512c5d95e15a72f12599d93909b9b83667023e190abc95c068bf76"
    }
  }
]